Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 61, Issue 7, Pages 3126-3137Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acs.jmedchem.8b00156
Keywords
-
Categories
Funding
- Deutsche Forschungsgemeinschaft [GRK880/3]
- Albert and Anneliese Konanz-Stiftung
Ask authors/readers for more resources
We studied the chemical entities within N-octanoyl dopamine (NOD) responsible for the activation of transient-receptor-potential channels of the vanilloid-receptor subtype 1 (TRPV1) and inhibition of inflammation. The potency of NOD in activating TRPV1 was significantly higher compared with those of variants in which the ortho-dihydroxy groups were acetylated, one of the hydroxy groups was omitted (N-octanoyl tyramine), or the ester functionality consisted of a bulky fatty acid (N-pivaloyl dopamine). Shortening of the amide linker (Delta NOD) slightly increased its potency, which was further increased when the carbonyl and amide groups (Delta NODR) were interchanged. With the exception of Delta NOD, the presence of an intact catechol structure was obligatory for the inhibition of VCAM-1 and the induction of HO-1 expression. Because TRPV1 activation and the inhibition of inflammation by N-acyl dopamines require different structural entities, our findings provide a framework for the rational design of TRPV1 agonists with improved anti-inflammatory properties.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available